More on FBIO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.73 |
|
|||
| Open | $2.75 | ||||
| 52 Wk High | $4.66 | ||||
| 52 Wk Low | $2.01 | ||||
| Day High | $2.76 | ||||
| Day Low | $2.70 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 81,326 | ||||
- Form 10-Q Fortress Biotech, Inc. For: Jun 30
- Form 8-K Fortress Biotech, Inc. For: Aug 13
- Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
- Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
- Form 10-Q MUSTANG BIO, INC. For: Jun 30
- Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
- Crystalys Therapeutics closes $130M Series B to fund gout drug trials
- Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
- Form 4 Fortress Biotech, Inc. For: Jun 22 Filed by: Jin David
- Form 8-K Fortress Biotech, Inc. For: Jun 17
Entities mentioned with FBIO
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- S3 | View Related Stories »
- H.C. Wainwright | View Related Stories »
- B. Riley | View Related Stories »
- Dividend | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
